|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,233.90 INR | +1.99% |
|
+1.31% | +9.76% |
| 03:42pm | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| 03:05pm | Glenmark Pharmaceuticals Limited Announces Management Changes, Effective August 1, 2026 | CI |
| Market Cap | 630B 6.6B 5.74B 5.34B 4.91B 9.26B 9.41B 62.98B 24.72B 314B 24.8B 24.26B 1,052B | P/E 2026 |
44.2x | P/E 2027 * | 26.8x |
|---|---|---|---|---|---|
| Enterprise Value | 591B 6.19B 5.38B 5.01B 4.6B 8.69B 8.82B 59.06B 23.18B 294B 23.26B 22.74B 987B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.56x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.24% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +1.99% | ||
| 1 week | +1.31% | ||
| Current month | +1.34% | ||
| 1 month | +1.34% | ||
| 3 months | -7.16% | ||
| 6 months | +10.81% | ||
| Current year | +9.76% |
| 1 week | 2,178.2 |  | 2,270.2 |
| 1 month | 2,142.8 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/1999 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 26/05/2025 |
Indrajit Bose
PSD | President | - | 14/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 11/05/2011 | |
| Director/Board Member | 85 | 13/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.99% | +1.31% | +3.73% | +179.67% | 6.47B | |
| -0.53% | +1.87% | +14.81% | +74.83% | 50.29B | |
| -1.81% | +1.69% | +53.40% | +106.05% | 37.24B | |
| +0.46% | +5.76% | -5.53% | +25.08% | 12.41B | |
| +1.05% | +1.17% | +13.23% | +75.93% | 11.65B | |
| -1.14% | +0.57% | +32.24% | +132.30% | 9.17B | |
| -2.99% | -0.60% | +43.05% | -8.54% | 7.24B | |
| +0.51% | +1.29% | +14.45% | +34.63% | 6.8B | |
| +0.39% | -4.81% | -34.14% | -1.07% | 5.46B | |
| +0.84% | +0.74% | +23.74% | +114.46% | 4.5B | |
| Average | -0.12% | +1.59% | +15.90% | +73.33% | 15.12B | |
| Weighted average by Cap. | -0.57% | +2.58% | +22.94% | +79.13% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.6B 1.39B 1.3B 1.19B 2.25B 2.28B 15.3B 6B 76.23B 6.02B 5.89B 256B | 167B 1.75B 1.52B 1.41B 1.3B 2.45B 2.49B 16.66B 6.54B 83B 6.56B 6.41B 278B |
| Net income | 20.53B 215M 187M 174M 160M 302M 306M 2.05B 805M 10.22B 808M 790M 34.27B | 23.28B 244M 212M 197M 181M 342M 347M 2.33B 913M 11.59B 916M 896M 38.87B |
| Net Debt | -39.29B -412M -358M -333M -306M -577M -586M -3.93B -1.54B -19.56B -1.55B -1.51B -65.6B | -37.12B -389M -338M -315M -289M -546M -554M -3.71B -1.46B -18.48B -1.46B -1.43B -61.97B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | ₹2,233.90 | +1.99% | 371,153 |
| 30/07/26 | ₹2,190.30 | -3.16% | 451,791 |
| 29/07/26 | ₹2,261.70 | +3.53% | 593,720 |
| 28/07/26 | ₹2,184.60 | -0.52% | 490,034 |
| 27/07/26 | ₹2,196.00 | +0.18% | 593,586 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
